| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,070 |
1,855 |
$323K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,464 |
4,932 |
$154K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
230 |
205 |
$69K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,870 |
5,482 |
$31K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
208 |
75 |
$27K |
| 80053 |
Comprehensive metabolic panel |
380 |
341 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
370 |
353 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
634 |
565 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
650 |
558 |
$10K |
| T1015 |
Clinic visit/encounter, all-inclusive |
120 |
106 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
922 |
871 |
$9K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14 |
13 |
$8K |
| 87428 |
|
239 |
220 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
247 |
218 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
246 |
235 |
$5K |
| 87081 |
|
98 |
94 |
$3K |
| 87400 |
|
78 |
76 |
$1K |
| 80061 |
Lipid panel |
27 |
26 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$969.42 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
24 |
24 |
$787.09 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$719.29 |
| 81001 |
|
40 |
39 |
$648.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
13 |
$538.29 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
34 |
26 |
$426.06 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
12 |
$423.80 |
| 85027 |
|
12 |
12 |
$177.19 |
| J2704 |
Injection, propofol, 10 mg |
17 |
12 |
$71.80 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42 |
40 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23 |
23 |
$0.00 |